Fenoverine vs. mefenamic acid in the treatment of primary dysmenorrhea

Saved in:
Bibliographic Details
Published inInternational journal of gynecology and obstetrics Vol. 93; no. 1; pp. 72 - 73
Main Authors Lira-Plascencia, J., Arzola-Paniagua, A., Carranza-Lira, S.
Format Journal Article
LanguageEnglish
Published Shannon Elsevier Ireland Ltd 01.04.2006
Elsevier Science
Subjects
Biological and medical sciences
Cross-Over Studies
Cyclooxygenase Inhibitors - administration & dosage
Cyclooxygenase Inhibitors - therapeutic use
Dysmenorrhea
Dysmenorrhea - drug therapy
Female
Female genital diseases
Fenoverine
Gynecology. Andrology. Obstetrics
Humans
Medical sciences
Mefenamic acid
Mefenamic Acid - administration & dosage
Mefenamic Acid - therapeutic use
Non tumoral diseases
Pain Measurement
Phenothiazines - administration & dosage
Phenothiazines - therapeutic use
Prospective Studies
Treatment Outcome
Mefenamic acid
Dysmenorrhea
Fenoverine
Prostaglandin-endoperoxide synthase
Menstruation disorders
Enzyme
Gynecology
Enzyme inhibitor
Obstetrics
Female genital diseases
Treatment
Primary
Anthranilic acid derivatives
Oxidoreductases
Comparative study
Online AccessGet full text

Cover

More Information
Bibliography:ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
ISSN:0020-7292
1879-3479
DOI:10.1016/j.ijgo.2006.01.006